(1)
Informative Censoring in CDK4 6 Inhibitor Adjuvant Therapy for Early Breast Cancer: A Sensitivity Analysis of Invasive Disease-Free Survival in the MonarchE Trial. ebph 2025. https://doi.org/10.54103/2282-0930/29562.